Stocks and Investing
Stocks and Investing
Fri, September 23, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John McNulty Maintained (CC) at Buy with Decreased Target to $46 on, Sep 23rd, 2022
John McNulty of BMO Capital, Maintained "The Chemours Company" (CC) at Buy with Decreased Target from $55 to $46 on, Sep 23rd, 2022.
John has made no other calls on CC in the last 4 months.
There are 3 other peers that have a rating on CC. Out of the 3 peers that are also analyzing CC, 2 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Joshua Spector of "UBS" Maintained at Hold with Increased Target to $37 on, Friday, July 29th, 2022
- Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $44 on, Tuesday, June 14th, 2022
This is the rating of the analyst that currently disagrees with John
- Arun Viswanathan of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Thursday, September 22nd, 2022
Contributing Sources